December Newsletter

Group K Diagnostic’s focus is to create a cost and time-effective point-of-care diagnostic solution.  
Happy Holidays! We're excited to show you all we've accomplished in the past year.  Check out our timeline below and stay tuned for updates in the new year.

If you haven't signed up before, we'd like to invite you to continue to follow us by clicking the subscribe button.

Thanks for joining!

Here at Group K, we've awaited clinical trials and the expansion of our diagnostic pipeline over the last year.  After we receive IRB approval, we are excited to announce that we will begin our first manufacturing run specifically for clinical trials.  We've also expanded our diagnostic pipeline to include a research partnership to bring a point of care liver cancer diagnostic to the market, and started on chemistry metabolic panel research. 

Emilia Lopez-Ona